n,n-dimethylarginine has been researched along with Hypertrophy, Left Ventricular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, AA; Leffler, KE | 1 |
| Atzler, D; Böger, RH; Chen, P; Chen, Y; Fassett, J; Guo, H; Hu, X; Kwak, D; Liu, X; Lu, Z; Schwedhelm, E; Wang, H; Xu, X; Yue, W; Zhang, P | 1 |
| Behairy, M; El Shahawy, Y; Mady, G; Rifaie, A; Shenawy, H; Soliman, Y | 1 |
| Baj, Z; Bartnicki, P; Franczyk-Skóra, B; Kowalczyk, M; Rysz, J | 1 |
| Delgado-Baeza, E; Quintana-Villamandos, B | 1 |
| Arinsoy, T; Bali, M; Demirtaş, C; Derici, U; Ebinç, FA; Ebinç, H; Erten, Y; Koç, E; Mutluay, R; Paşaoğlu, H; Reis, KA; Sindel, S; Taçoy, G | 1 |
| Cao, L; Fang, W; Gu, L; Mou, S; Ni, Z; Qian, J; Shi, B; Wang, Q; Yan, Y; Yu, Z; Zhou, W | 1 |
| Aizawa, K; Ishizuka, N; Iwabuchi, S; Kitamura, H; Moriguchi, Y; Nishimura, T; Serizawa, K; Tashiro, Y; Yogo, K; Yorozu, K | 1 |
| Bruno, RM; Ghiadoni, L; Grassi, G; Mancia, G; Seravalle, G; Tripepi, G; Zoccali, C | 1 |
| Całka, A; Górny, J; Graczykowska, A; Napora, M; Próchniewska, K; Stompór, T; Zdrojewski, Z | 1 |
| Janas, R; Litwin, M; Niemirska, A; Płudowski, P; Skorupa, E; Sladowska-Kozłowska, J; Wawer, ZT; Wierzbicka, A | 1 |
| Li, H; Wang, S | 1 |
| Fujii, H; Hiuge, A; Horio, T; Kamide, K; Kawano, Y; Nakatani, S; Ogihara, T; Rakugi, H; Takiuchi, S | 1 |
| Bellanuova, I; Benedetto, FA; Böger, R; Cataliotti, A; Maas, R; Malatino, LS; Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
1 trial(s) available for n,n-dimethylarginine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Organic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.
Topics: Adult; Aged; Antihypertensive Agents; Arginine; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |
13 other study(ies) available for n,n-dimethylarginine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Restoration of Adiponectin-Connexin43 Signaling Mitigates Myocardial Inflammation and Dysfunction in Diabetic Female Rats.
Topics: Adiponectin; Animals; Arginine; Connexin 43; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Estradiol; Estrogen Receptor alpha; Female; Heme Oxygenase (Decyclizing); Hypertrophy, Left Ventricular; Ovariectomy; Piperidines; Rats, Wistar; Receptors, Adiponectin; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Topics: Amidohydrolases; Animals; Arginine; Atrial Natriuretic Factor; Disease Models, Animal; Fibrosis; Genetic Predisposition to Disease; Hypertrophy, Left Ventricular; Male; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide; Phenotype; Signal Transduction; Tyrosine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Relationship between asymmetric dimethylarginine plasma level and left ventricular mass in hemodialysis patients.
Topics: Adult; Arginine; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Organ Size; Renal Dialysis; Ultrasonography; Ventricular Dysfunction, Left | 2015 |
Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Nitric Oxide Synthase Type III; Renal Dialysis; Renal Insufficiency, Chronic; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
Topics: Adrenergic beta-1 Receptor Antagonists; Amidohydrolases; Animals; Antihypertensive Agents; Arginine; Humans; Hypertension; Hypertrophy, Left Ventricular; Models, Cardiovascular; Nitric Oxide; Propanolamines; Rats; Rats, Inbred SHR; Risk Factors; Signal Transduction; Ventricular Remodeling | 2016 |
The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Case-Control Studies; Creatinine; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertrophy, Left Ventricular; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Multivariate Analysis; Peritoneal Dialysis, Continuous Ambulatory; Probability; Reference Values; Regression Analysis; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; Ultrasonography | 2008 |
Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.
Topics: Adult; Arginine; Female; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2010 |
Left ventricular hypertrophy is associated with inflammation in sodium loaded subtotal nephrectomized rats.
Topics: Animals; Arginine; Creatinine; Disease Models, Animal; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Nephrectomy; Parathyroid Hormone; Phosphates; Rats; Rats, Wistar; Risk Factors; Sclerosis; Sodium Chloride | 2011 |
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chronic Disease; Cross-Sectional Studies; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypertrophy, Left Ventricular; Italy; Kidney; Kidney Diseases; Linear Models; Male; Proteinuria; Risk Assessment; Risk Factors; Severity of Illness Index; Sympathetic Fibers, Postganglionic; Ventricular Remodeling | 2011 |
Relationship between serum asymmetric dimethylarginine and left ventricular structure and function in patients with end‑stage renal disease treated with hemodialysis.
Topics: Arginine; Biomarkers; Echocardiography; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Ventricular Dysfunction, Left | 2012 |
Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.
Topics: Adiposity; Adolescent; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Biomarkers; Blood Pressure; C-Reactive Protein; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Child; Child, Preschool; Cholesterol, LDL; Female; Glutathione Peroxidase; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoproteins, LDL; Male; Metabolic Syndrome; Oxidative Stress; Poland; Severity of Illness Index; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome | 2012 |
Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
Topics: Aged; Arginine; Coronary Circulation; Echocardiography, Doppler; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Male; Middle Aged | 2004 |
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.
Topics: Adult; Aged; Arginine; Echocardiography; Endothelium, Vascular; Female; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Nitric Oxide; Renal Dialysis; Vasodilation; Ventricular Dysfunction, Left | 2002 |